286 related articles for article (PubMed ID: 28334938)
41. Novel
Arshad F; Vengalil S; Maskomani S; Kamath SD; Kulanthaivelu K; Mundlamuri RC; Yadav R; Nalini A
Neurocase; 2021 Dec; 27(6):484-489. PubMed ID: 34983323
[TBL] [Abstract][Full Text] [Related]
42. Application of whole exome sequencing in undiagnosed inherited polyneuropathies.
Klein CJ; Middha S; Duan X; Wu Y; Litchy WJ; Gu W; Dyck PJ; Gavrilova RH; Smith DI; Kocher JP; Dyck PJ
J Neurol Neurosurg Psychiatry; 2014 Nov; 85(11):1265-72. PubMed ID: 24604904
[TBL] [Abstract][Full Text] [Related]
43. Genetic disorders with central nervous system white matter abnormalities: An update.
Shukla A; Kaur P; Narayanan DL; do Rosario MC; Kadavigere R; Girisha KM
Clin Genet; 2021 Jan; 99(1):119-132. PubMed ID: 33047326
[TBL] [Abstract][Full Text] [Related]
44. The use of targeted genomic capture and massively parallel sequencing in diagnosis of Chinese Leukoencephalopathies.
Wang X; He F; Yin F; Chen C; Wu L; Yang L; Peng J
Sci Rep; 2016 Oct; 6():35936. PubMed ID: 27779215
[TBL] [Abstract][Full Text] [Related]
45. High Diagnostic Utility Incorporating a Targeted Neurodegeneration Gene Panel With MRI Brain Diagnostic Algorithms in Patients With Young-Onset Cognitive Impairment With Leukodystrophy.
Chen Z; Tan YJ; Lian MM; Tandiono M; Foo JN; Lim WK; Kandiah N; Tan EK; Ng ASL
Front Neurol; 2021; 12():631407. PubMed ID: 33597917
[TBL] [Abstract][Full Text] [Related]
46. [Association between homozygous c.318A>GT mutation in exon 2 of the EIF2B5 gene and the infantile form of vanishing white matter leukoencephalopathy].
Esmer C; Blanco Hernández G; Saavedra Alanís V; Reyes Vaca JG; Bravo Oro A
Bol Med Hosp Infant Mex; 2017; 74(5):364-369. PubMed ID: 29382480
[TBL] [Abstract][Full Text] [Related]
47. Adult-onset genetic leukoencephalopathies: a MRI pattern-based approach in a comprehensive study of 154 patients.
Ayrignac X; Carra-Dalliere C; Menjot de Champfleur N; Denier C; Aubourg P; Bellesme C; Castelnovo G; Pelletier J; Audoin B; Kaphan E; de Seze J; Collongues N; Blanc F; Chanson JB; Magnin E; Berger E; Vukusic S; Durand-Dubief F; Camdessanche JP; Cohen M; Lebrun-Frenay C; Brassat D; Clanet M; Vermersch P; Zephir H; Outteryck O; Wiertlewski S; Laplaud DA; Ouallet JC; Brochet B; Goizet C; Debouverie M; Pittion S; Edan G; Deburghgraeve V; Le Page E; Verny C; Amati-Bonneau P; Bonneau D; Hannequin D; Guyant-Maréchal L; Derache N; Defer GL; Moreau T; Giroud M; Guennoc AM; Clavelou P; Taithe F; Mathis S; Neau JP; Magy L; Devoize JL; Bataillard M; Masliah-Planchon J; Dorboz I; Tournier-Lasserve E; Levade T; Boespflug Tanguy O; Labauge P
Brain; 2015 Feb; 138(Pt 2):284-92. PubMed ID: 25527826
[TBL] [Abstract][Full Text] [Related]
48. AARS2 Compound Heterozygous Variants in a Case of Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia.
Wang D; Yu M; Zhang W; Wang Z; Yuan Y
J Neuropathol Exp Neurol; 2018 Nov; 77(11):997-1000. PubMed ID: 30272204
[TBL] [Abstract][Full Text] [Related]
49. Further expanding the mutational spectrum of brain abnormalities, neurodegeneration, and dysosteosclerosis: A rare disorder with neurologic regression and skeletal features.
Kındış E; Simsek-Kiper PÖ; Koşukcu C; Taşkıran EZ; Göçmen R; Utine E; Haliloğlu G; Boduroğlu K; Alikaşifoğlu M
Am J Med Genet A; 2021 Jun; 185(6):1888-1896. PubMed ID: 33749994
[TBL] [Abstract][Full Text] [Related]
50. Ovarioleukodystrophy due to EIF2B5 mutations.
Ibitoye RT; Renowden SA; Faulkner HJ; Scolding NJ; Rice CM
Pract Neurol; 2016 Dec; 16(6):496-499. PubMed ID: 27651498
[TBL] [Abstract][Full Text] [Related]
51. Diagnosis, prognosis, and treatment of leukodystrophies.
van der Knaap MS; Schiffmann R; Mochel F; Wolf NI
Lancet Neurol; 2019 Oct; 18(10):962-972. PubMed ID: 31307818
[TBL] [Abstract][Full Text] [Related]
52. Hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS): update on molecular genetics.
Stabile C; Taglia I; Battisti C; Bianchi S; Federico A
Neurol Sci; 2016 Sep; 37(9):1565-9. PubMed ID: 27338940
[TBL] [Abstract][Full Text] [Related]
53. Hypomyelinating leukodystrophies in adults: Clinical and genetic features.
Di Bella D; Magri S; Benzoni C; Farina L; Maccagnano C; Sarto E; Moscatelli M; Baratta S; Ciano C; Piacentini SHMJ; Draghi L; Mauro E; Pareyson D; Gellera C; Taroni F; Salsano E
Eur J Neurol; 2021 Mar; 28(3):934-944. PubMed ID: 33190326
[TBL] [Abstract][Full Text] [Related]
54. Parkinsonian features in hereditary diffuse leukoencephalopathy with spheroids (HDLS) and CSF1R mutations.
Sundal C; Fujioka S; Van Gerpen JA; Wider C; Nicholson AM; Baker M; Shuster EA; Aasly J; Spina S; Ghetti B; Roeber S; Garbern J; Tselis A; Swerdlow RH; Miller BB; Borjesson-Hanson A; Uitti RJ; Ross OA; Stoessl AJ; Rademakers R; Josephs KA; Dickson DW; Broderick D; Wszolek ZK
Parkinsonism Relat Disord; 2013 Oct; 19(10):869-77. PubMed ID: 23787135
[TBL] [Abstract][Full Text] [Related]
55. Clinical and genetic characterization of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia associated with CSF1R mutation.
Konno T; Yoshida K; Mizuno T; Kawarai T; Tada M; Nozaki H; Ikeda SI; Nishizawa M; Onodera O; Wszolek ZK; Ikeuchi T
Eur J Neurol; 2017 Jan; 24(1):37-45. PubMed ID: 27680516
[TBL] [Abstract][Full Text] [Related]
56. Diagnostic odyssey in severe neurodevelopmental disorders: toward clinical whole-exome sequencing as a first-line diagnostic test.
Thevenon J; Duffourd Y; Masurel-Paulet A; Lefebvre M; Feillet F; El Chehadeh-Djebbar S; St-Onge J; Steinmetz A; Huet F; Chouchane M; Darmency-Stamboul V; Callier P; Thauvin-Robinet C; Faivre L; Rivière JB
Clin Genet; 2016 Jun; 89(6):700-7. PubMed ID: 26757139
[TBL] [Abstract][Full Text] [Related]
57. Hereditary leukoencephalopathy with axonal spheroids: a spectrum of phenotypes from CNS vasculitis to parkinsonism in an adult onset leukodystrophy series.
Lynch DS; Jaunmuktane Z; Sheerin UM; Phadke R; Brandner S; Milonas I; Dean A; Bajaj N; McNicholas N; Costello D; Cronin S; McGuigan C; Rossor M; Fox N; Murphy E; Chataway J; Houlden H
J Neurol Neurosurg Psychiatry; 2016 May; 87(5):512-9. PubMed ID: 25935893
[TBL] [Abstract][Full Text] [Related]
58. [Vanishing white matter disease, a rare leukodystrophy with mutation in the EIF2B5 gene].
Sinkó G; Tompa M; Kiss Z; Kálmán B
Ideggyogy Sz; 2024 May; 77(5-6):207-211. PubMed ID: 38829246
[TBL] [Abstract][Full Text] [Related]
59. Four Swedish cases of CSF1R-related leukoencephalopathy: Visualization of clinical phenotypes.
Rosenstein I; Andersen O; Victor D; Englund E; Granberg T; Hedberg-Oldfors C; Jood K; Fitrah YA; Ikeuchi T; Danylaité Karrenbauer V
Acta Neurol Scand; 2022 May; 145(5):599-609. PubMed ID: 35119108
[TBL] [Abstract][Full Text] [Related]
60. Novel partial deletions, frameshift and missense mutations of CSF1R in patents with CSF1R-related leukoencephalopathy.
Ishiguro T; Konno T; Hara N; Zhu B; Okada S; Shibata M; Saika R; Kitano T; Toko M; Nezu T; Hama Y; Kawazoe T; Takahashi-Iwata I; Yabe I; Sato K; Takeda H; Toda S; Nishimiya J; Teduka T; Nozaki H; Kasuga K; Miyashita A; Onodera O; Ikeuchi T
Eur J Neurol; 2023 Jul; 30(7):1861-1870. PubMed ID: 36943150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
